Cargando…

Development and evaluation of a rapid nucleic acid amplification method to detect influenza A and B viruses in human respiratory specimens

Isothermal nucleic acid amplification methods can potentially shorten the amount of time required to diagnose influenza. We developed and evaluated a novel isothermal nucleic acid amplification method, RT-SIBA to rapidly detect and differentiate between influenza A and B viruses in a single reaction...

Descripción completa

Detalles Bibliográficos
Autores principales: Elf, Sonja, Auvinen, Pauliina, Jahn, Lisa, Liikonen, Karoliina, Sjöblom, Solveig, Saavalainen, Päivi, Mäki, Minna, Eboigbodin, Kevin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127616/
https://www.ncbi.nlm.nih.gov/pubmed/29778563
http://dx.doi.org/10.1016/j.diagmicrobio.2018.04.006
_version_ 1783516398717239296
author Elf, Sonja
Auvinen, Pauliina
Jahn, Lisa
Liikonen, Karoliina
Sjöblom, Solveig
Saavalainen, Päivi
Mäki, Minna
Eboigbodin, Kevin E.
author_facet Elf, Sonja
Auvinen, Pauliina
Jahn, Lisa
Liikonen, Karoliina
Sjöblom, Solveig
Saavalainen, Päivi
Mäki, Minna
Eboigbodin, Kevin E.
author_sort Elf, Sonja
collection PubMed
description Isothermal nucleic acid amplification methods can potentially shorten the amount of time required to diagnose influenza. We developed and evaluated a novel isothermal nucleic acid amplification method, RT-SIBA to rapidly detect and differentiate between influenza A and B viruses in a single reaction tube. The performance of the RT-SIBA Influenza assay was compared with two established RT-PCR methods. The sensitivities of the RT-SIBA, RealStar RT-PCR, and CDC RT-PCR assays for the detection of influenza A and B viruses in the clinical specimens were 98.8%, 100%, and 89.3%, respectively. All three assays demonstrated a specificity of 100%. The average time to positive result was significantly shorter with the RT-SIBA Influenza assay (<20 min) than with the two RT-PCR assays (>90 min). The method can be run using battery-operated, portable devices with a small footprint and therefore has potential applications in both laboratory and near-patient settings.
format Online
Article
Text
id pubmed-7127616
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71276162020-04-08 Development and evaluation of a rapid nucleic acid amplification method to detect influenza A and B viruses in human respiratory specimens Elf, Sonja Auvinen, Pauliina Jahn, Lisa Liikonen, Karoliina Sjöblom, Solveig Saavalainen, Päivi Mäki, Minna Eboigbodin, Kevin E. Diagn Microbiol Infect Dis Article Isothermal nucleic acid amplification methods can potentially shorten the amount of time required to diagnose influenza. We developed and evaluated a novel isothermal nucleic acid amplification method, RT-SIBA to rapidly detect and differentiate between influenza A and B viruses in a single reaction tube. The performance of the RT-SIBA Influenza assay was compared with two established RT-PCR methods. The sensitivities of the RT-SIBA, RealStar RT-PCR, and CDC RT-PCR assays for the detection of influenza A and B viruses in the clinical specimens were 98.8%, 100%, and 89.3%, respectively. All three assays demonstrated a specificity of 100%. The average time to positive result was significantly shorter with the RT-SIBA Influenza assay (<20 min) than with the two RT-PCR assays (>90 min). The method can be run using battery-operated, portable devices with a small footprint and therefore has potential applications in both laboratory and near-patient settings. Elsevier Inc. 2018-09 2018-04-18 /pmc/articles/PMC7127616/ /pubmed/29778563 http://dx.doi.org/10.1016/j.diagmicrobio.2018.04.006 Text en © 2018 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Elf, Sonja
Auvinen, Pauliina
Jahn, Lisa
Liikonen, Karoliina
Sjöblom, Solveig
Saavalainen, Päivi
Mäki, Minna
Eboigbodin, Kevin E.
Development and evaluation of a rapid nucleic acid amplification method to detect influenza A and B viruses in human respiratory specimens
title Development and evaluation of a rapid nucleic acid amplification method to detect influenza A and B viruses in human respiratory specimens
title_full Development and evaluation of a rapid nucleic acid amplification method to detect influenza A and B viruses in human respiratory specimens
title_fullStr Development and evaluation of a rapid nucleic acid amplification method to detect influenza A and B viruses in human respiratory specimens
title_full_unstemmed Development and evaluation of a rapid nucleic acid amplification method to detect influenza A and B viruses in human respiratory specimens
title_short Development and evaluation of a rapid nucleic acid amplification method to detect influenza A and B viruses in human respiratory specimens
title_sort development and evaluation of a rapid nucleic acid amplification method to detect influenza a and b viruses in human respiratory specimens
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127616/
https://www.ncbi.nlm.nih.gov/pubmed/29778563
http://dx.doi.org/10.1016/j.diagmicrobio.2018.04.006
work_keys_str_mv AT elfsonja developmentandevaluationofarapidnucleicacidamplificationmethodtodetectinfluenzaaandbvirusesinhumanrespiratoryspecimens
AT auvinenpauliina developmentandevaluationofarapidnucleicacidamplificationmethodtodetectinfluenzaaandbvirusesinhumanrespiratoryspecimens
AT jahnlisa developmentandevaluationofarapidnucleicacidamplificationmethodtodetectinfluenzaaandbvirusesinhumanrespiratoryspecimens
AT liikonenkaroliina developmentandevaluationofarapidnucleicacidamplificationmethodtodetectinfluenzaaandbvirusesinhumanrespiratoryspecimens
AT sjoblomsolveig developmentandevaluationofarapidnucleicacidamplificationmethodtodetectinfluenzaaandbvirusesinhumanrespiratoryspecimens
AT saavalainenpaivi developmentandevaluationofarapidnucleicacidamplificationmethodtodetectinfluenzaaandbvirusesinhumanrespiratoryspecimens
AT makiminna developmentandevaluationofarapidnucleicacidamplificationmethodtodetectinfluenzaaandbvirusesinhumanrespiratoryspecimens
AT eboigbodinkevine developmentandevaluationofarapidnucleicacidamplificationmethodtodetectinfluenzaaandbvirusesinhumanrespiratoryspecimens